Effect of Hypericum perforatum extract on behavioural studies in experimentally induced neurodegenerative disease
Article Sidebar
-
Behavioral studies, Hypericum perforatum, MPTP, Parkinson’s disease
Abstract
Parkinson's disease (PD) is a common neurodegenerative movement disease affecting a large number of people worldwide. In animals, the intracranial or systemical application of the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) can result in severe injury to the nigrostriatal dopaminergic system. Hypericum perforatum is a plant generally used as an antidepressant that also has anti-inflammatory and antioxidant properties. Hypericum perforatum has been used to lessen the mild to moderate symptoms of depression. The present study was done to find the effect of Hypericum perforatum methanolic extract pretreatment and post-treatment on behavioral studies in MPTP induced Parkinson’s disease model. The behavioral assessments were performed with a forced swim test, pole test, tail suspension test, and catalepsy test. Hypericum perforatum extract ameliorated depressive-like behavior better in post-treatment as compared with pretreatment group in MPTP model of Parkinson's disease. It can be said that Hypericum perforatum methanolic extract might be a therapeutic agent for the treatment of PD, but further clinical studies are required.
Full text article
References
Ben-Eliezer, D., Yechiam, E. 2016. Hypericum perforatum as a cognitive enhancer in rodents: A meta- analysis. Scientific Reports, 6(1):35700.
Bhattacharjee, N., Mazumder, M. K., Paul, R., Choudhury, A., Choudhury, S., Borah, A. 2016. L-DOPA treatment in MPTP-mouse model of Parkinson’s disease potentiates homocysteine accumulation in substantia nigra. Neuroscience Letters, 628:225–229.
Cao, Z., Wang, F., Xiu, C., Zhang, J., Li, Y. 2017. Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer’s disease rats. Biomedicine and Pharmacotherapy, 91:931–937.
Chen, Y., Zhang, Y., Li, L., Hölscher, C. 2015. Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson’s disease. European Journal of Pharmacology, 768:21–27.
Chonpathompikunlert, P., Boonruamkaew, P., Sukketsiri, W., Hutamekalin, P., Sroyraya, M. 2018. The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice. BMC Complementary and Alternative Medicine, 18(1):103–103.
De Pablo-Fernández, E., Lees, A. J., Holton, J. L., Warner, T. T. 2019. Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease. JAMA Neurology, 76(4):470–479.
Deng, H., Wang, P., Jankovic, J. 2018. The genetics of Parkinson disease. Ageing Research Reviews, 42:72–85.
German-Ponciano, L. J., Rosas-Sánchez, G. U. 2018. Advances in the Preclinical Study of Some Flavonoids as Potential Antidepressant Agents. Scientifica, 2018:1–14.
Kasahara, J., Choudhury, M. E., Nishikawa, N., Tanabe, A., et al. 2017. Neurotoxin 1-methyl-4-phenyl- 1, 2, 3, 6-tetrahydropyridine (MPTP)-induced animal models of Parkinson’s disease. In Animal models for the study of human disease, Academic Press. page: 1087-1108.
Kiasalari, Z., Baluchnejadmojarad, T., Roghani, M. 2016. Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease. Cellular and Molecular Neurobiology, 36(4):521–530.
Kordjazy, N., Haj-Mirzaian, A., Amiri, S., Ostadhadi, S., Amini-khoei, H., Dehpour, A. R. 2016. Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test. Pharmacology Biochemistry and Behavior, 141:1–9.
Ng, Q. X., Venkatanarayanan, N., Ho, C. Y. X. 2017. Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. Journal of Affective Disorders, 210:211–221.
Pałucha-Poniewiera, A., Podkowa, K., Lenda, T., Pilc, A. 2017. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 79:155–161.
Poleszak, E., Szopa, A., Bogatko, K. 2019. Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist. Neurotoxicity Research, 35(2):344–352.
Ramalhete, N., Machado, A., Serrano, R., Gomes, E. T., Mota-Filipe, H., Silva, O. 2016. Comparative study on the in vivo antidepressant activities of the Portuguese Hypericum foliosum, Hypericum androsaemum and Hypericum perforatum medicinal plants. Industrial Crops and Products, 82:29– 36.
Vajdi-Hokmabad, R., Ziaee, M., Sadigh-Eteghad, S., Shotorbani, S. S., Mahmoudi, J. 2017. Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease;Possible Involvement of Dopaminergic Neurotransmission. Advanced Pharmaceutical Bulletin, 7(3):359–365.
Yang, J. S., Wu, X. H., Yu, H. G., Teng, L. S. 2017. Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced Parkinson’s disease dementia in rats. Inflammopharmacology, 25(4):471–484.
Yao, K., Zhao, Y. F. 2018. Aging modulates microgliaphenotypes in neuroinflammation of MPTP-PD mice. Experimental gerontology, 111:86–93.
Zirak, N., Shafiee, M., Soltani, G., Mirzaei, M., Sahebkar, A. 2019. Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action. Journal of Cellular Physiology, 234(6):8496–8508.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.